Lipe & Dalton’s Abbott ABT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $143K | Buy |
1,580
+160
| +11% | +$14.6K | 0.07% | 75 |
|
|
2026
Q1 | $146K | Buy |
1,420
+400
| +39% | +$45.2K | 0.08% | 74 |
|
|
2025
Q4 | $128K | Sell |
1,020
-410
| -29% | -$52.2K | 0.06% | 79 |
|
|
2025
Q3 | $192K | Sell |
1,430
-300
| -17% | -$39.4K | 0.1% | 76 |
|
|
2025
Q2 | $235K | Hold |
1,730
| – | – | 0.13% | 72 |
|
|
2025
Q1 | $229K | Buy |
+1,730
| New | +$220K | 0.13% | 72 |
|
|
2024
Q4 | – | Sell |
-1,980
| Closed | -$226K | – | 94 |
|
|
2024
Q3 | $226K | Hold |
1,980
| – | – | 0.11% | 81 |
|
|
2024
Q2 | $206K | Sell |
1,980
-34
| -2% | -$3.6K | 0.11% | 79 |
|
|
2024
Q1 | $229K | Hold |
2,014
| – | – | 0.12% | 78 |
|
|
2023
Q4 | $222K | Hold |
2,014
| – | – | 0.12% | 78 |
|
|
2023
Q3 | $195K | Hold |
2,014
| – | – | 0.12% | 79 |
|
|
2023
Q2 | $220K | Hold |
2,014
| – | – | 0.13% | 75 |
|
|
2023
Q1 | $204K | Hold |
2,014
| – | – | 0.12% | 77 |
|
|
2022
Q4 | $221K | Sell |
2,014
-300
| -13% | -$31.1K | 0.13% | 72 |
|
|
2022
Q3 | $224K | Hold |
2,314
| – | – | 0.14% | 72 |
|
|
2022
Q2 | $251K | Hold |
2,314
| – | – | 0.15% | 72 |
|
|
2022
Q1 | $274K | Hold |
2,314
| – | – | 0.13% | 73 |
|
|
2021
Q4 | $326K | Buy |
2,314
+34
| +1% | +$4.35K | 0.15% | 73 |
|
|
2021
Q3 | $269K | Sell |
2,280
-150
| -6% | -$18.4K | 0.14% | 72 |
|
|
2021
Q2 | $282K | Hold |
2,430
| – | – | 0.15% | 71 |
|
|
2021
Q1 | $291K | Hold |
2,430
| – | – | 0.16% | 67 |
|
|
2020
Q4 | $266K | Buy |
2,430
+300
| +14% | +$32.6K | 0.16% | 64 |
|
|
2020
Q3 | $232K | Hold |
2,130
| – | – | 0.16% | 67 |
|
|
2020
Q2 | $195K | Hold |
2,130
| – | – | 0.14% | 69 |
|
|
2020
Q1 | $168K | Hold |
2,130
| – | – | 0.14% | 68 |
|
|
2019
Q4 | $185K | Hold |
2,130
| – | – | 0.12% | 72 |
|
|
2019
Q3 | $178K | Sell |
2,130
-20
| -0.9% | -$1.7K | 0.13% | 73 |
|
|
2019
Q2 | $181K | Hold |
2,150
| – | – | 0.13% | 68 |
|
|
2019
Q1 | $172K | Hold |
2,150
| – | – | 0.13% | 68 |
|
|
2018
Q4 | $156K | Hold |
2,150
| – | – | 0.13% | 66 |
|
|
2018
Q3 | $158K | Hold |
2,150
| – | – | 0.11% | 64 |
|
|
2018
Q2 | $131K | Buy |
2,150
+150
| +8% | +$9.09K | 0.1% | 66 |
|
|
2018
Q1 | $120K | Buy |
2,000
+20
| +1% | +$1.21K | 0.09% | 71 |
|
|
2017
Q4 | $113K | Hold |
1,980
| – | – | 0.08% | 71 |
|
|
2017
Q3 | $106K | Hold |
1,980
| – | – | 0.07% | 70 |
|
|
2017
Q2 | $96K | Hold |
1,980
| – | – | 0.06% | 73 |
|
|
2017
Q1 | $88K | Buy |
+1,980
| New | +$85.6K | 0.06% | 73 |
|
Other funds holding ABT
Lipe & Dalton's ABT Position: Q2 2026 in Review
Lipe & Dalton increased its Abbott (ABT) stake by 11% in Q2 2026, buying an estimated $14.6K and bringing the position to 1,580 shares worth $143K. The position accounts for 0.07% of the portfolio, ranked #75.
Lipe & Dalton first reported a position in ABT in Q1 2017 and has held it in 37 quarters since. The position peaked at $326K in Q4 2021. 2,963 funds tracked by Wall St. Rank hold ABT as of Q2 2026.
- Lipe & Dalton held 1,580 shares of Abbott worth $143K as of Q2 2026.
- Lipe & Dalton bought 160 Abbott shares in Q2 2026, an estimated $14.6K.
- Abbott made up 0.07% of Lipe & Dalton's portfolio in Q2 2026, its #75 holding.
- Lipe & Dalton first reported a position in Abbott in Q1 2017 and has held it in 37 quarters since.
- Lipe & Dalton's Abbott position peaked at $326K in Q4 2021.
- 2,963 funds tracked by Wall St. Rank held Abbott as of Q2 2026.
Based on Lipe & Dalton's 13F filing for Q2 2026, filed 14 Jul 2026.